David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Northern Oil and Gas
NOG
$2.82B
| $618K | ﹤0.01% |
24,900
+1,800
| +8% | +$47.7K |
|
3627
CVRx
CVRX
$89.8M
| $617K | ﹤0.01% |
76,449
+23,074
| +43% | +$173K |
|
|
GAP
3628
CALL
The Gap Inc
GAP
$7.25B
| $616K | ﹤0.01% |
28,800
-151,400
| -84% | -$3.27M |
|
3629
Fidelity MSCI Information Technology Index ETF
FTEC
$20.6B
| $615K | ﹤0.01% |
2,770
-2,700
| -49% | -$561K |
|
3630
St. Joe Company
JOE
$3.96B
| $614K | ﹤0.01% |
12,410
-67,490
| -84% | -$3.4M |
|
3631
CALL
Bank of America
BAC
$437B
| $614K | ﹤0.01% |
11,900
-78,400
| -87% | -$3.82M |
|
|
BIOA
3632
BioAge Labs
BIOA
$464M
| $613K | ﹤0.01% |
104,281
+36,883
| +55% | +$173K |
|
|
CIVI
3633
DELISTED
Civitas Resources
CIVI
| $611K | ﹤0.01% |
18,800
+8,265
| +78% | +$264K |
|
3634
Vanda Pharmaceuticals
VNDA
$329M
| $610K | ﹤0.01% |
122,327
-41,817
| -25% | -$194K |
|
3635
Samsara
IOT
$22.8B
| $610K | ﹤0.01% |
16,367
-18,934
| -54% | -$703K |
|
3636
CALL
Oxford Industries
OXM
$549M
| $608K | ﹤0.01% |
+15,000
| New | +$650K |
|
3637
TechTarget
TTGT
$281M
| $607K | ﹤0.01% |
104,539
+70,273
| +205% | +$466K |
|
3638
Nice
NICE
$5.88B
| $607K | ﹤0.01% |
+4,195
| New | +$629K |
|
3639
MGE Energy Inc
MGEE
$2.99B
| $605K | ﹤0.01% |
7,191
-575
| -7% | -$49.1K |
|
|
ATXS
3640
DELISTED
Astria Therapeutics
ATXS
| $604K | ﹤0.01% |
82,925
+529
| +0.6% | +$3.58K |
|
3641
Novartis
NVS
$304B
| $603K | ﹤0.01% |
4,706
-7,866
| -63% | -$960K |
|
3642
Westamerica Bancorp
WABC
$1.34B
| $603K | ﹤0.01% |
12,053
-16,340
| -58% | -$809K |
|
3643
Carlyle Secured Lending
CGBD
$785M
| $600K | ﹤0.01% |
+47,963
| New | +$658K |
|
3644
Financial Institutions
FISI
$800M
| $599K | ﹤0.01% |
+22,009
| New | +$587K |
|
3645
Avantis Emerging Markets Equity ETF
AVEM
$28B
| $598K | ﹤0.01% |
7,965
-2,264
| -22% | -$162K |
|
3646
CALL
Genie Energy
GNE
$406M
| $598K | ﹤0.01% |
+40,000
| New | +$716K |
|
3647
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.44B
| $598K | ﹤0.01% |
5,883
-600
| -9% | -$59.4K |
|
3648
iShares MSCI USA Equal Weighted ETF
EUSA
$1.95B
| $598K | ﹤0.01% |
5,804
| – | – |
|
3649
Gladstone Investment Corp
GAIN
$657M
| $596K | ﹤0.01% |
+43,149
| New | +$608K |
|
3650
ProFrac Holding
ACDC
$851M
| $596K | ﹤0.01% |
+160,999
| New | +$887K |
|
Similar funds
David Shaw's Q3 2025 Portfolio in Review
As of Q3 2025, David Shaw held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- David Shaw's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- David Shaw added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- David Shaw's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- David Shaw fully exited Hess in Q3 2025, selling an estimated $527M.
- David Shaw's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- David Shaw opened 714 new positions and closed 514 in Q3 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.